Headinvest »

Oncolytics Biotech shares owned by Headinvest

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Headinvest from 13F filings

Historical chart of Headinvest investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Headinvest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Headinvest

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 12k 1.35
2023-09-30 $24k 12k 2.09
2023-06-30 $23k 12k 2.03

More positions owned by Headinvest

Ishares Core S&p Small Cap Etf Etf (IJR)
Microsoft Corp Stock (MSFT)
Procter And Gamble Stock (PG)
Novo-nordisk A S Adr (NVO)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Accenture Plc Ireland Shs Class A Stock (ACN)
Intuit Stock (INTU)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Large-cap Etf Etf (VV)
Danaher Corporation Stock (DHR)
Vanguard Short-term Bond Etf Etf (BSV)
Apple Stock (AAPL)
Fiserv Stock (FI)
Waters Corp Stock (WAT)
Pepsico Stock (PEP)

View all positions for Headinvest

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech